VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

UKONS 2020 | COVID-19: launching a self-administration service

Fleur Harvey • 19 Nov 2020
UKONS 2020
General Antibodies Bortezomib Cytarabine Trastuzumab

Fleur Harvey, The Royal Marsden NHS Foundation Trust, London, UK, discusses the launch of a self-administration service during COVID-19 with four agents (cytarabine, bortezomib, trastuzumab, denosumab) at the Royal Marsden NHS Foundation Trust. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Fleur Harvey

1:13
COVID-19-mediated streamlining of processes in the UK
Fleur Harvey • 19 Nov 2020

Related Videos

2:39
Improving diversity in clinical trial enrollment
Lola A. Fashoyin-Aje • 15 Jan 2021
7:32
Updates on MRx0518 + pembro in patients with resistance to therapy
Alex Stevenson • 27 Nov 2020
5:05
Development of the cancer nursing workforce
Andreas Charalambous • 23 Nov 2020
3:09
Impact of COVID-19 on oncology nursing
Andreas Charalambous • 23 Nov 2020
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals